Relay Therapeutics Inc. (RLAY)
NASDAQ: RLAY
· Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT
Relay Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.36M | 7.68M | 10.01M | 10.01M | 35.21M | 35.33M | 25.55M | 25.8M | 942K | 1.19M | 1.38M | 1.7M | 2.02M | 2.5M | 3.03M | 85.12M | 84.45M | 83.61M |
Cost of Revenue | 3.7M | 4.07M | 5.46M | 5.5M | 5.5M | 5.47M | 5.27M | 5.06M | 4.73M | 63.91M | 63.69M | 63.55M | 106.67M | 91.31M | 120.96M | 187.66M | 167.88M | 144.4M |
Gross Profit | -1.26M | -2.3M | -1.37M | -67.99M | -42.78M | -42.63M | -52.21M | 20.74M | -3.79M | -62.72M | -62.3M | -61.86M | -104.66M | -88.81M | -117.93M | -102.55M | -83.43M | -60.8M |
Operating Income | -343.06M | -366.97M | -372.47M | -379.69M | -356.89M | -362.19M | -373M | -353.65M | -365.97M | -337.73M | -299.27M | -293.88M | -268.98M | -384.75M | -364.43M | -261.99M | -237.6M | -71.74M |
Interest Income | 32.17M | 33.61M | 34.75M | 34.47M | 34.04M | 33.05M | 31.05M | 27.72M | 21.59M | 15.03M | 8.79M | 3.68M | 2.13M | 1.3M | 830K | 859K | 1.24M | 2.05M |
Pretax Income | -311.55M | -333.39M | -337.71M | -345.2M | -322.83M | -329.12M | -341.97M | -325.98M | -344.42M | -322.7M | -290.51M | -290.46M | -267.12M | -383.73M | -363.87M | -261.14M | -236.38M | -69.71M |
Net Income | -311.55M | -333.39M | -337.71M | -345.2M | -322.83M | -329.12M | -335.04M | -294.86M | -316.38M | -294.67M | -258.85M | -282.99M | -256.56M | -373.17M | -363.87M | -261.14M | -236.38M | -69.71M |
Selling & General & Admin | 69.02M | 74.16M | 73.83M | 73.69M | 72.43M | 73.78M | 74.95M | 74.56M | 72.14M | 69.49M | 65.98M | 65.15M | 63.76M | 60.72M | 57.39M | 57.38M | 54.93M | 46.56M |
Research & Development | 282.4M | 310.5M | 319.09M | 328.51M | 333.38M | 329.59M | 330.02M | 319.8M | 305.2M | 277.51M | 246.35M | 230.99M | 209.06M | 193.69M | 172.65M | 152.87M | 132.27M | 108.79M |
Other Expenses | -1.33M | -1.33M | -1.33M | -75.93M | -77.13M | -77.15M | -77.15M | -1.24M | -34K | -2K | -20K | 4K | 2M | 1.98M | 2M | 1.99M | -17K | -21K |
Operating Expenses | 350.09M | 383.32M | 391.58M | 326.27M | 328.68M | 326.24M | 327.84M | 393.15M | 377.35M | 347M | 312.33M | 296.14M | 272.82M | 254.41M | 230.04M | 210.25M | 187.2M | 155.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -1.37M | -2.76M | -2.76M | -2.76M | -1.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 351.42M | 374.65M | 382.48M | 389.69M | 392.1M | 399.67M | 401.7M | 393.15M | 377.35M | 347M | 312.33M | 296.14M | 272.82M | 254.41M | 230.04M | 210.25M | 187.2M | 155.35M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -6.94M | -31.13M | -28.04M | -28.04M | -31.66M | -7.47M | -10.4M | -10.22M | 559K | 847K | 690K | 509K |
Shares Outstanding (Basic) | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
Shares Outstanding (Diluted) | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
EPS (Basic) | -1.95 | -2.23 | -2.39 | -2.62 | -2.53 | -2.65 | -2.75 | -2.43 | -2.68 | -2.58 | -2.34 | -2.64 | -2.51 | -3.9 | -3.89 | -2.73 | -2.58 | -6.54 |
EPS (Diluted) | -1.95 | -2.23 | -2.39 | -2.62 | -2.53 | -2.65 | -2.75 | -2.43 | -2.68 | -2.58 | -2.34 | -2.64 | -2.51 | -3.9 | -3.89 | -2.73 | -2.58 | -6.54 |
EBITDA | -340.36M | -374.28M | -380.21M | -389.45M | -367.87M | -363.97M | -374.15M | -363.49M | -371.68M | -341.46M | -306.82M | -291.01M | -267.4M | -248.51M | -223.65M | -121.04M | -98.76M | -67.85M |
EBIT | -328.79M | -370.54M | -385.67M | -394.96M | -373.37M | -369.44M | -379.42M | -368.55M | -376.41M | -345.82M | -310.95M | -295.01M | -273.22M | -389M | -364.09M | -261.65M | -237.42M | -71.74M |
Depreciation & Amortization | 3.91M | 5.28M | 5.46M | 5.5M | 5.5M | 5.47M | 5.27M | 5.06M | 4.73M | 4.35M | 4.13M | 4M | 3.98M | 3.98M | 3.92M | 3.8M | 3.7M | 3.61M |